SNDL Inc.

SNDL

CA83307B1013

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
2.36 ^USD	-1.67%		-9.92%	+43.90%

May. 09	Transcript : SNDL Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09	SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024	CI

Sundial Growers Inc. Announces Elizabeth Cannon Not to Stand for Re-Election as Member of the Board

June 21, 2021 at 08:22 am EDT

Sundial Growers Inc. announced that in its forthcoming Annual General Meeting of shareholders to be held on July 7, 2021, Dr. Elizabeth Cannon has elected not to stand for re-election as a member of the Board.

Latest news about SNDL Inc.

Transcript : SNDL Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024	May. 09	CI
Earnings Flash (SNDL) SNDL Reports Q1 Revenue C$197.8M	May. 09	MT
Nova Cannabis Brief: SNDL Inc. and Nova Completed Assignment of SNDL's Rights to Own or Operate Four Dutch Love Stores to Nova Upon the Terms Announced on April 1, 2024	May. 09	MT
SNDL Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Cannabis Stocks Rise Pre-Bell After Florida Supreme Court Allows Ballot Initiative to Legalize Marijuana	Apr. 02	MT
Pot producers climb as recreational cannabis to go on Florida ballot	Apr. 02	RE
Nova Cannabis Brief: SNDL and Nova Cannabis Announced Overnight Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility	Apr. 02	MT
Nova Cannabis Rises 5% As Swings To Q4 Profit YOY	Mar. 26	MT
Nova Cannabis Swings To Q4 Profit YOY	Mar. 26	MT
Transcript : SNDL Inc., Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
North American Morning Briefing : Investors -2-	Mar. 21	DJ
Earnings Flash (SNDL) SNDL Reports Q4 Revenue $248.5M	Mar. 21	MT
Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 13, 2023.	Mar. 20	CI
Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 16, 2022.	Mar. 20	CI
SNDL Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
SNDL Inc.'s Equity Buyback announced on November 16, 2022, has expired with 2,863,849 shares, representing 1.21% for CAD 6.35 million.	Nov. 29	CI
SNDL, Nova Cannabis Terminate Implementation Agreement; Nova down 11.7%	Nov. 20	MT
SNDL, Nova Cannabis Terminate Implementation Agreement	Nov. 20	MT
SNDL Inc. and Nova Cannabis Inc. Announces the Mutual Decision to Terminate the Implementation Agreement	Nov. 20	CI
Nova Cannabis Inc. cancelled the acquisition of 26 cannabis retail stores located in Ontario and Alberta from SNDL Inc..	Nov. 16	CI
Transcript : SNDL Inc., Q3 2023 Earnings Call, Nov 13, 2023	Nov. 13
SNDL Inc. announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.	Nov. 13	CI
Earnings Flash (SNDL) SNDL Posts Q3 Revenue $237.6M	Nov. 13	MT
Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 16, 2022.	Nov. 13	CI

Chart SNDL Inc.

Duration

Period

More charts

Company Profile

SNDL Inc. is a Canada-based private-sector liquor and cannabis retailer in Canada with retail banners, which include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, and Firesale Cannabis. Its segments include Liquor Retail, Cannabis Retail, Cannabis Operations and Investments. The Liquor Retail segment includes the sale of wines, beers and spirits through liquor stores. The Cannabis Retail segment includes the private sale of recreational cannabis through and franchise retail cannabis stores. The Cannabis Operations segment includes the cultivation, distribution and sale of cannabis for the adult-use and medical markets domestically and for export, and providing cannabis processing services, in addition to product development, manufacturing, and commercialization of cannabis consumer packaged goods. The Investments segment includes the deployment of capital to investment opportunities. Its cannabis brand portfolio includes Top Leaf, Vacay, Grasslands and others.

Sector

Pharmaceuticals

Calendar

2024-08-13 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for SNDL Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.266 CAD

Average target price

4.957 CAD

Spread / Average Target

+51.77%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SNDL INC.	+43.90%	632M
ELI LILLY AND COMPANY	+37.78%	705B
NOVO NORDISK A/S	+32.82%	583B
JOHNSON & JOHNSON	-3.51%	364B
MERCK & CO., INC.	+19.94%	332B
ABBVIE INC.	+5.14%	291B
ASTRAZENECA PLC	+16.64%	238B
ROCHE HOLDING AG	-4.13%	210B
NOVARTIS AG	+10.63%	209B
AMGEN INC.	+9.32%	169B

Other Pharmaceuticals

SNDL Inc.

Equities

SNDL

CA83307B1013

Pharmaceuticals

Sundial Growers Inc. Announces Elizabeth Cannon Not to Stand for Re-Election as Member of the Board

EPS Revisions